Too Much Fuel on the Fire? Linking Obesity, Metabolism, and Melanoma Outcomes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36315002.
- Also identified by DOI 10.1158/1078-0432.CCR-22-3028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with metastatic melanoma who are overweight or obese have improved outcomes when treated with immunotherapies or targeted therapies. A recent study provides the first evidence that the host metabolic state influences the tumor metabolic phenotype, with implications for tumor progression and therapeutic response. See related article by Hahn et al., p. 154.
Medical subject headings
- Melanoma
- Neoplasms, Second Primary